Patent Assignment
Reel/Frame 068269/0513
Assignment of Assignor's Interest
Recorded: 2024-08-13
Pages: 14
Assignors
CHOW, TAK CHEUNG ANDREW
Executed: 2023-10-12
MASUDA, ESTEBAN
Executed: 2023-10-17
TAYLOR, VANESSA CLAIRE
Executed: 2023-12-01
Assignee
RIGEL PHARMACEUTICALS, INC.
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Formulations and Dosing Regimens for RIP1 Kinase Inhibitors for Treating Autoimmune and Inflammatory Diseases
Application:
18/745,814 →
Publication:
US 2025/0000872
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 13, 2024
From: ABERNATHY, MATTHEW M.; DAIRAGHI, DANIEL; KIELBASA, WILLIAM BRIAN; SPERRY, DAVID CHARLES
To: ELI LILLY AND COMPANY
Reel/Frame 068268/0144 →
Security Interest
May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →